首页 | 本学科首页   官方微博 | 高级检索  
     

替考拉宁治疗重症监护病房革兰阳性菌重症感染临床报道
引用本文:冒四平,郭昌星,林兆奋,单红卫,杨兴易,陈德昌,赵良. 替考拉宁治疗重症监护病房革兰阳性菌重症感染临床报道[J]. 中华医院感染学杂志, 2010, 20(1)
作者姓名:冒四平  郭昌星  林兆奋  单红卫  杨兴易  陈德昌  赵良
作者单位:1. 伊宁农四师医院外二科,新疆,伊宁,835000
2. 上海长征医院急救科,上海,200003
摘    要:
目的评价替考拉宁治疗重症监护病房(ICU)革兰阳性菌所致重症感染的临床疗效及安全性。方法共完成30例临床病例观察,替考拉宁400 mg加入生理盐水250 ml中静脉滴注,1次/24 h,疗程7~10 d。结果30例病例观察痊愈率为70.00%,有效率为83.33%,细菌清除率为86.67%,不良反应发生率为6.67%。结论调查结果表明替考拉宁治疗革兰阳性菌所致重症感染是安全、有效的。

关 键 词:替考拉宁  重症感染  重症监护病房

Teicoplanin on Patients with Severe Infection in ICU
MAO Si-ping,GUO Chang-xing,LIN Zhao-fen,SHAN Hong-wei,YANG Xing-yi,CHEN De-chang,ZHAO Liang. Teicoplanin on Patients with Severe Infection in ICU[J]. Chinese Journal of Nosocomiology, 2010, 20(1)
Authors:MAO Si-ping  GUO Chang-xing  LIN Zhao-fen  SHAN Hong-wei  YANG Xing-yi  CHEN De-chang  ZHAO Liang
Affiliation:MAO Si-ping,GUO Chang-xing,LIN Zhao-fen,SHAN Hong-wei,YANG Xing-yi,CHEN De-chang,ZHAO Liang(Yining Nongsishi Hospital,Yining,Xinjiang 835000,China)
Abstract:
OBJECTIVE To evaluate the efficacy and safety of teicoplanin on the patients with severe infection in ICU.METHODS Thirty cases were observed and the dosage of drug was 400mg once a day for injection.The duration of the treatment was 7-10 days.RESULTS The total cure rate was 70.00%,the total response was 83.33%,and the bacterial clearance rate was 86.67%.CONCLUSIONS Teicoplanin is both effective and safe for patients with severe infection in ICU.
Keywords:Teieoplanin  Severe infection  ICU
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号